1bz4 Citations

Conformational flexibility in the apolipoprotein E amino-terminal domain structure determined from three new crystal forms: implications for lipid binding.

Protein Sci 9 886-97 (2000)
Related entries: 1or2, 1or3

Cited: 36 times
EuropePMC logo PMID: 10850798

Abstract

An amino-terminal fragment of human apolipoprotein E3 (residues 1-165) has been expressed and crystallized in three different crystal forms under similar crystallization conditions. One crystal form has nearly identical cell dimensions to the previously reported orthorhombic (P2(1)2(1)2(1)) crystal form of the amino-terminal 22 kDa fragment of apolipoprotein E (residues 1-191). A second orthorhombic crystal form (P2(1)2(1)2(1) with cell dimensions differing from the first form) and a trigonal (P3(1)21) crystal form were also characterized. The structures of the first orthorhombic and the trigonal form were determined by seleno-methionine multiwavelength anomalous dispersion, and the structure of the second orthorhombic form was determined by molecular replacement using the structure from the trigonal form as a search model. A combination of modern experimental and computational techniques provided high-quality electron-density maps, which revealed new features of the apolipoprotein E structure, including an unambiguously traced loop connecting helices 2 and 3 in the four-helix bundle and a number of multiconformation side chains. The three crystal forms contain a common intermolecular, antiparallel packing arrangement. The electrostatic complimentarity observed in this antiparallel packing resembles the interaction of apolipoprotein E with the monoclonal antibody 2E8 and the low density lipoprotein receptor. Superposition of the model structures from all three crystal forms reveals flexibility and pronounced kinks in helices near one end of the four-helix bundle. This mobility at one end of the molecule provides new insights into the structural changes in apolipoprotein E that occur with lipid association.

Reviews - 1bz4 mentioned but not cited (1)

Articles - 1bz4 mentioned but not cited (10)

  1. Calculation of accurate small angle X-ray scattering curves from coarse-grained protein models. Stovgaard K, Andreetta C, Ferkinghoff-Borg J, Hamelryck T. BMC Bioinformatics 11 429 (2010)
  2. Rationally designed carbohydrate-occluded epitopes elicit HIV-1 Env-specific antibodies. Zhu C, Dukhovlinova E, Council O, Ping L, Faison EM, Prabhu SS, Potter EL, Upton SL, Yin G, Fay JM, Kincer LP, Spielvogel E, Campbell SL, Benhabbour SR, Ke H, Swanstrom R, Dokholyan NV. Nat Commun 10 948 (2019)
  3. Adaptation-proof SARS-CoV-2 vaccine design. Vishweshwaraiah YL, Hnath B, Rackley B, Wang J, Gontu A, Chandler M, Afonin KA, Kuchipudi SV, Christensen N, Yennawar NH, Dokholyan NV. Adv Funct Mater 32 2206055 (2022)
  4. Structure prediction for the helical skeletons detected from the low resolution protein density map. Al Nasr K, Sun W, He J. BMC Bioinformatics 11 Suppl 1 S44 (2010)
  5. Constrained Cyclic Coordinate Descent for Cryo-EM Images at Medium Resolutions: Beyond the Protein Loop Closure Problem. Nasr KA, He J. Robotica 34 1777-1790 (2016)
  6. The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. Chakraborty S, Rendón-Ramírez A, Ásgeirsson B, Dutta M, Ghosh AS, Oda M, Venkatramani R, Rao BJ, Dandekar AM, Goñi FM. F1000Res 2 286 (2013)
  7. Three-Dimensional Graph Matching to Identify Secondary Structure Correspondence of Medium-Resolution Cryo-EM Density Maps. Behkamal B, Naghibzadeh M, Saberi MR, Tehranizadeh ZA, Pagnani A, Al Nasr K. Biomolecules 11 1773 (2021)
  8. Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer's Disease drug candidate. Nemergut M, Marques SM, Uhrik L, Vanova T, Nezvedova M, Gadara DC, Jha D, Tulis J, Novakova V, Planas-Iglesias J, Kunka A, Legrand A, Hribkova H, Pospisilova V, Sedmik J, Raska J, Prokop Z, Damborsky J, Bohaciakova D, Spacil Z, Hernychova L, Bednar D, Marek M. Mol Neurodegener 18 38 (2023)
  9. Network Pharmacology and Molecular Docking-Based Strategy to Investigate the Multitarget Mechanisms of Shenqi Yizhi Granule on Alzheimer's Disease. Wang L, Xu X, Wang Z, Chen Q, Wei X, Xue J, Zhang Z, Wang M, Li Y, Zhang J, Wei D. Evid Based Complement Alternat Med 2022 8032036 (2022)
  10. Chimeric antigens displaying GPR65 extracellular loops on a soluble scaffold enabled the discovery of antibodies, which recognized native receptor. Barrett J, Leysen S, Galmiche C, Al-Mossawi H, Bowness P, Edwards TE, Lawson ADG. Bioengineered 15 2299522 (2024)


Reviews citing this publication (3)

  1. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Nat Rev Neurol 15 501-518 (2019)
  2. The helix bundle: a reversible lipid binding motif. Narayanaswami V, Kiss RS, Weers PM. Comp Biochem Physiol A Mol Integr Physiol 155 123-133 (2010)
  3. Apolipoprotein structure and dynamics. Gursky O. Curr Opin Lipidol 16 287-294 (2005)

Articles citing this publication (22)

  1. Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease. Morrow JA, Hatters DM, Lu B, Hochtl P, Oberg KA, Rupp B, Weisgraber KH. J Biol Chem 277 50380-50385 (2002)
  2. Two divalent metal ions in the active site of a new crystal form of human apurinic/apyrimidinic endonuclease, Ape1: implications for the catalytic mechanism. Beernink PT, Segelke BW, Hadi MZ, Erzberger JP, Wilson DM, Rupp B. J Mol Biol 307 1023-1034 (2001)
  3. Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine. Peters-Libeu CA, Newhouse Y, Hatters DM, Weisgraber KH. J Biol Chem 281 1073-1079 (2006)
  4. Structural analysis of lipid complexes of GM2-activator protein. Wright CS, Zhao Q, Rastinejad F. J Mol Biol 331 951-964 (2003)
  5. Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism. Acharya P, Segall ML, Zaiou M, Morrow J, Weisgraber KH, Phillips MC, Lund-Katz S, Snow J. Biochim Biophys Acta 1584 9-19 (2002)
  6. Modulation of the lipid binding properties of the N-terminal domain of human apolipoprotein E3. Weers PM, Narayanaswami V, Ryan RO. Eur J Biochem 268 3728-3735 (2001)
  7. Quantifying size distributions of nanolipoprotein particles with single-particle analysis and molecular dynamic simulations. Blanchette CD, Law R, Benner WH, Pesavento JB, Cappuccio JA, Walsworth V, Kuhn EA, Corzett M, Chromy BA, Segelke BW, Coleman MA, Bench G, Hoeprich PD, Sulchek TA. J Lipid Res 49 1420-1430 (2008)
  8. A unified scheme for initiation and conformational adaptation of human apolipoprotein E N-terminal domain upon lipoprotein binding and for receptor binding activity. Sivashanmugam A, Wang J. J Biol Chem 284 14657-14666 (2009)
  9. Engineering conformational destabilization into mouse apolipoprotein E. A model for a unique property of human apolipoprotein E4. Hatters DM, Peters-Libeu CA, Weisgraber KH. J Biol Chem 280 26477-26482 (2005)
  10. Structural determinates for apolipoprotein E-derived peptide interaction with the alpha7 nicotinic acetylcholine receptor. Gay EA, Bienstock RJ, Lamb PW, Yakel JL. Mol Pharmacol 72 838-849 (2007)
  11. Outliers in SAR and QSAR: is unusual binding mode a possible source of outliers? Kim KH. J Comput Aided Mol Des 21 63-86 (2007)
  12. The N-terminus of apolipoprotein A-V adopts a helix bundle molecular architecture. Wong K, Beckstead JA, Lee D, Weers PM, Guigard E, Kay CM, Ryan RO. Biochemistry 47 8768-8774 (2008)
  13. Apolipoprotein E phylogeny and evolution. Kasap M, Sazci A, Akpinar G, Ergul E. Cell Biochem Funct 26 43-50 (2008)
  14. Mechanism of Lipid Binding of Human Apolipoprotein E3 by Hydrogen/Deuterium Exchange/Mass Spectrometry and Fluorescence Polarization. Fabilane CS, Nguyen PN, Hernandez RV, Nirudodhi S, Duong M, Maier CS, Narayanaswami V. Protein Pept Lett 23 404-413 (2016)
  15. Replacement of helix 1' enhances the lipid binding activity of apoE3 N-terminal domain. Redmond KA, Murphy C, Narayanaswami V, Kiss RS, Hauser P, Guigard E, Kay CM, Ryan RO. FEBS J 273 558-567 (2006)
  16. Structural basis for abrogated binding between staphylococcal enterotoxin A superantigen vaccine and MHC-IIalpha. Krupka HI, Segelke BW, Ulrich RG, Ringhofer S, Knapp M, Rupp B. Protein Sci 11 642-651 (2002)
  17. Three-dimensional theory of emittance in Compton scattering and x-ray protein crystallography. Hartemann FV, Baldis HA, Kerman AK, Le Foll A, Luhmann NC, Rupp B. Phys Rev E Stat Nonlin Soft Matter Phys 64 016501 (2001)
  18. Ordered opening of LDL receptor binding domain of human apolipoprotein E3 revealed by hydrogen/deuterium exchange mass spectrometry and fluorescence spectroscopy. Yang L, Hernandez RV, Tran TN, Nirudodhi S, Beck WHJ, Maier CS, Narayanaswami V. Biochim Biophys Acta Proteins Proteom 1866 1165-1173 (2018)
  19. The LDL receptor binding domain of apolipoprotein E directs the relative orientation of its C-terminal segment in reconstituted nascent HDL. Kothari S, Bala N, Patel AB, Donovan A, Narayanaswami V. Biochim Biophys Acta Biomembr 1863 183618 (2021)
  20. Coenzyme Q10, antioxidant status and ApoE isoforms. Battino M, Giunta S, Galeazzi L, Galeazzi R, Mosca F, Santolini C, Principi F, Ferretti G, Bacchetti T, Bencivenga R, Piani M, Riganello G, Littarru GP. Biofactors 18 299-305 (2003)
  21. Differences in Recycling of Apolipoprotein E3 and E4-LDL Receptor Complexes-A Mechanistic Hypothesis. Kim M, Bezprozvanny I. Int J Mol Sci 22 5030 (2021)
  22. Next-Generation Sequencing of a Large Gene Panel for Outcome Prediction of Bariatric Surgery in Patients with Severe Obesity. Bonetti G, Dhuli K, Ceccarini MR, Kaftalli J, Samaja M, Precone V, Cecchin S, Maltese PE, Guerri G, Marceddu G, Beccari T, Aquilanti B, Velluti V, Matera G, Perrone M, Iaconelli A, Colombo F, Greco F, Raffaelli M, Ergoren MC, Bertelli M. J Clin Med 11 7531 (2022)